UMIN-CTR History

Name：　　UMIN ID：


Unique ID issued by UMIN UMIN000003394
Receipt number R000004080
Scientific Title Phase 2 study of Pemetrexed + Carboplatin as first line therapy for non-squamous non-small cell lung cancer with EGFR Mutation (CJLSG0907)
Date of disclosure of the study information 2010/03/29
Last modified on 2019/03/31 05:44:21

No. Disposal Last modified on Item of update
1 Insert 2010/03/28 23:07:31
2 Update 2011/03/28 19:36:14 Name of person sending information
Organization
Division name
Address
3 Update 2011/09/29 07:58:16 Post marketing survey by drug manufacture etc., specified by Japanese law.
4 Update 2012/03/29 15:15:49 Last follow-up date
5 Update 2013/10/07 13:13:47 TEL
Email
Address
Address
TEL
6 Update 2014/05/01 15:55:35 Recruitment status
7 Update 2018/06/29 18:50:12 Name of primary person or sponsor
Organization
Email1
8 Update 2019/03/31 05:38:24 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code

Last name of contact person

Last name of contact person
Zip code
Organization
Organization
Address
Address
Tel
Email
9 Update 2019/03/31 05:44:21 Recruitment status
Date of IRB